CADM1andMALpromoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease

Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: Implications for natural history and management

(2012) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical and Pathological Heterogeneity of Cervical Intraepithelial Neoplasia Grade 3

(2012) Hannah P. Yang et al.   PLoS One

Population-based case–control study on DAPK1, RAR-β2 and MGMT methylation in liquid-based cytology

(2011) Lu-lu Sun et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Combined Promoter Methylation Analysis of CADM1 and MAL: An Objective Triage Tool for High-Risk Human Papillomavirus DNA-Positive Women

(2011) A. T. Hesselink et al.   CLINICAL CANCER RESEARCH

Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection

(2011) Mariska Bierkens et al.   INTERNATIONAL JOURNAL OF CANCER

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients

(2011) J.J.H. Eijsink et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results

(2010) Cuei Jyuan Lin et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Cervical dysplasia: Assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy

(2010) Elaine H. Lim et al.   GYNECOLOGIC ONCOLOGY

Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women

(2010) Renée M. Overmeer et al.   INTERNATIONAL JOURNAL OF CANCER

Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix

(2010) Nabiha Missaoui et al.   PATHOLOGY RESEARCH AND PRACTICE

Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens

(2010) Jo-Heon Kim et al.   VIRCHOWS ARCHIV

Methylation Markers for CCNA1 and C13ORF18 Are Strongly Associated with High-Grade Cervical Intraepithelial Neoplasia and Cervical Cancer in Cervical Scrapings

(2009) N. Yang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Chromosomal Signatures of a Subset of High-Grade Premalignant Cervical Lesions Closely Resemble Invasive Carcinomas

(2009) S. M. Wilting et al.   CANCER RESEARCH

DNA methylation analysis in liquid-based cytology for cervical cancer screening

(2009) Sophia Apostolidou et al.   INTERNATIONAL JOURNAL OF CANCER

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis

(2009) Renée M Overmeer et al.   JOURNAL OF PATHOLOGY

Utility of methylation markers in cervical cancer early detection: Appraisal of the state-of-the-science

(2008) Nicolas Wentzensen et al.   GYNECOLOGIC ONCOLOGY

Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma

(2008) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC

(2008) RM Overmeer et al.   JOURNAL OF PATHOLOGY

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

(2008) Margaret RE McCredie et al.   LANCET ONCOLOGY